Ocular Therapeutix Garners $14,000,000 Series D Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=9b9ea9d6-6d64-40d6-b71c-fa095d8e4174&Preview=1 - Date
2/2/2011 - Company Name
Ocular Therapeutix - Mailing Address
36 Crosby Dr. Bedford, MA 01730 - Company Description
Ocular Therapeutix, Inc. is a privately held company focused on the development and commercialization of ophthalmic therapeutic products using its proprietary hydrogel technology to address unmet or underserved needs in ophthalmology and ophthalmic surgery. - Website
http://www.ocutx.com - Transaction Type
Venture Equity - Transaction Amount
$14,000,000 - Transaction Round
Series D - Proceeds Purposes
The funding will be used to support Ocular Therapeutix’s Phase II clinical trials across a variety of therapeutic areas. The first trial will be conducted to reinforce safety and test efficacy of their first sustained drug delivery system, a moxifloxacin-loaded punctum plug. - M&A Terms
- Venture Investor
Ascension Health Ventures - Venture Investor
Polaris Venture Partners - Venture Investor
SV Life Sciences - Venture Investor
Versant Ventures
